Novo Holdings A/S’s Intersect ENT, Inc XENT Stock Holding History

Novo Holdings A/S’s Portfolio XENT Stock Details XENT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-508,922	Closed	-$8.7M	–	56
2021 Q2	$8.7M	Hold	508,922	–	–	0.39%	40
2021 Q1	$10.6M	Buy	508,922 +6,697	+1%	+$155K	0.44%	33
2020 Q4	$11.5M	Sell	502,225 -11,290	-2%	-$215K	0.49%	32
2020 Q3	$8.38M	Sell	513,515 -45,000	-8%	-$815K	0.42%	33
2020 Q2	$7.56M	Buy	558,515 +187,920	+51%	+$2.19M	0.49%	27
2020 Q1	$4.39M	Buy	370,595 +152,886	+70%	+$3.39M	0.29%	25
2019 Q4	$5.42M	Hold	217,709	–	–	0.35%	22
2019 Q3	$3.7M	Buy	217,709 +80,824	+59%	+$1.47M	0.63%	23
2019 Q2	$3.12M	Buy	+136,885	New	+$3.69M	0.44%	26
2015 Q1	–	Sell	-350,000	Closed	-$8M	–	15
2014 Q4	$6.49M	Hold	350,000	–	–	0.53%	14
2014 Q3	$5.42M	Buy	+350,000	New	+$5.27M	0.53%	13

Other funds holding XENT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

Versor Investments New York $40.8M AUM 93.59% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Novo Holdings A/S's XENT Position: Q3 2021 in Review

Novo Holdings A/S sold out of Intersect ENT, Inc (XENT) in Q3 2021, closing a stake of 508,922 shares — an estimated $8.7M sold.

Novo Holdings A/S first reported a position in XENT in Q3 2014 and held it in 11 quarters. The position peaked at $11.5M in Q4 2020. 123 funds tracked by Wall St. Rank hold XENT as of Q3 2021.

Novo Holdings A/S reported no remaining Intersect ENT, Inc position as of Q3 2021 after selling out during the quarter.
Novo Holdings A/S sold 508,922 Intersect ENT, Inc shares in Q3 2021, an estimated $8.7M.
Novo Holdings A/S first reported a position in Intersect ENT, Inc in Q3 2014 and held it in 11 quarters.
Novo Holdings A/S's Intersect ENT, Inc position peaked at $11.5M in Q4 2020.
123 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q3 2021.

Based on Novo Holdings A/S's 13F filing for Q3 2021, filed 15 Nov 2021.